Slingshot members are tracking this event:

Regeneron (REGN) and Sanofi (SNY) to Present Data from Phase 3 Praluent (alirocumab) Injection Clinical Trials at AHA Scientific Sessions 2016

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
REGN Community voting in process
SNY Community voting in process
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Praluent, Alirocumab, Aha Scientific Sessions 2016, Phase 3, Odyssey